期刊文献+

心理护理干预对多发性硬化患者治疗效果的影响 被引量:3

Effects of psychological nursing intervention on multiple sclerosis patients
原文传递
导出
摘要 【目的】观察心理护理干预对多发性硬化(multiple sclerosis,MS)患者治疗效果的影响,探讨提高MS疗效的护理措施。【方法】随机将2006年12月-2010年12月的126例MS住院患者分为对照组和干预组各63例,对照组给予常规护理措施,干预组在常规护理措施的基础上加强心理护理干预。应用汉密顿抑郁量表(HAMD)及汉密顿焦虑量表(HAMA)评估患者的精神状况,对两组患者治疗前后焦虑、抑郁及治疗依从性情况进行评分。【结果】治疗后,两组患者的焦虑和抑郁程度均有所下降,而干预组焦虑和抑郁评分均低于对照组,差异有统计学意义(P<0.05);干预组的治疗依从性(90.5%)高于对照组(74.6%),差异有统计学意义(χ2=5.507,P<0.05)。【结论】在MS治疗过程中,重视加强心理护理干预,有助于改善其抑郁、焦虑情绪,以提高MS患者的治疗效果,提高生活质量。 [Objective] To observe the clinical influence of psychological nursing intervention on the therapeutic effects of patients with multiple sclerosis (MS) and to explore the nursing methods for MS patients. [Methods] From December 2008 to December 2010, 126 inpatient MS patients were equally randomized into control group (accept conventional nursing and intervention group accept psychological nursing intervention based on the conventional nursing). HAMD and HAMA were used to evaluate the patients mental status, given the psychological intervention, and then compared the anxiety, depression score and treatment compliance before and after the therapy. [ Results] After the treatment, the levels of anxiety and depression were decreased in both groups and the scores of anxiety and depression in the intervention group were significantly lower than those of the control group (P 〈 0.05). The satisfaction rate of medical compliance in the interventional group(90.5%)was higher than that(74.6%)as the control group( X 2 = 5.507, P 〈 0.05). [Conclusion ] During the treatment of MS, to think highly of psychological nursing intervention may to improve depression, anxiety sentiment and life quality.
出处 《武警后勤学院学报(医学版)》 CAS 2012年第8期625-627,共3页 Journal of Logistics University of PAP(Medical Sciences)
关键词 多发性硬化 心理干预 脱髓鞘 焦虑 抑郁 Multiple sclerosis Psychological nursing Demyelination Anxiety Depression
  • 相关文献

参考文献10

二级参考文献72

  • 1张赛春,霍春暖,殷容光,张晓兰.早期心理康复对多发性硬化患者抑郁症状的效果观察[J].现代护理(上旬版),2007,13(3):612-613. 被引量:2
  • 2Lexell EM,Lund ML,Iwarsson S.Constantly changing lives:experiences of people with multiple sclerosis[J].Am J Occup Ther,2009,63(6):772-781.
  • 3Conway D,Cohen JA.Combination therapy in multiple sclerosis[J].Lancet Neurol.2010;9(3):299-308.
  • 4Patti F.Optimizing the benefit of multiple sclerosis therapy:the importance of treatment adherence[J].Patient Prefer Adherence,2010,4:1-9.
  • 5Brajkovi L,Bras M,Milunovi V,et al.The connection between coping mechanisms,depression,anxiety and fatigue in multiple sclerosis[J].Coll Antropol,2009,33 Suppl 2:S135-140.
  • 6Sospedra M,Martin R.Immunology of multiple sclerosis[J].Annu Rev Immanol,2005,23:683.
  • 7Bielecki B,Mazurek A,Wolinski P,et al.Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC[J].J Clin Immunol,2008,28(2):122-130.
  • 8Zivadinov R,Zorzon M,De Masi R.Effect of intravenous methylprednisolone on the number size and confluence of plaques in relapsing-remitting multiple sclerosis[J].J Neurol Sci,2008,267(1-2):28-35.
  • 9Paul F,Waiczies S,Wuerfel J,et al.Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis[J].Plos One,2008,3(4):1928-1932.
  • 10Wiesemann E,Deb M,Hemmer B,et al.Early identification of interferon-beta responders by exvivo testing in patients with multiple sclerosis[J].Clin Immunol,2008,127(3):405-409.

共引文献19

同被引文献21

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部